In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: The Mayo Clinic in Florida experience

Johnny Ray Bernard, Laura A. Vallow, Elizabeth R. DePeri, Rebecca B. McNeil, Deborah G. Feigel, Surabhi Amar, Steven J. Buskirk, Edith A. Perez

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The role of magnetic resonance imaging (MRI) in patients with newly diagnosed breast cancer is somewhat controversial. The purpose of this study was to evaluate the prevalence of synchronous, occult contralateral breast cancer detected by MRI but not by mammography or clinical breast examination in women with newly diagnosed breast cancer, including those aged 70 years or older at our institution. MRI results for women with newly diagnosed breast cancer who underwent bilateral breast MRI after negative mammography and clinical examination between February 2003 and ovember 2007 at Mayo Clinic in Florida were reviewed. The prevalence of pathologically confirmed contralateral carcinoma diagnosed solely by MRI was determined and analyzed in the context of age, family history, menopausal status, breast density, and primary-tumor characteristics. Logistic regression was used to explore the association between contralateral carcinoma and potential patient risk factors. A total of 425 women were evaluated, of whom 129 (30%) were aged 70 years or older. A contralateral biopsy was recommended and performed solely on the basis of MRI in 72 of the 425 women (17%). Sixteen of these 72 women (22%) had pathologically confirmed carcinoma, including seven in the older subgroup. The prevalence of clinically and mammographically occult contralateral carcinoma detected by MRI was 3.8% (16/425) overall and 5.4% (7/129) in the group of older women. When potential risk factors for contralateral breast cancer were evaluated, postmenopausal status was the only significant predictor of contralateral cancer detected by MRI (p = 0.016). We concluded that contralateral breast screening with MRI should be considered in postmenopausal women with newly diagnosed breast cancer, even those aged 70 years or older at diagnosis

Original languageEnglish (US)
Pages (from-to)118-126
Number of pages9
JournalBreast Journal
Volume16
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Early Detection of Cancer
Breast
Magnetic Resonance Imaging
Breast Neoplasms
Neoplasms
Carcinoma
Mammography
Logistic Models
Biopsy

Keywords

  • Breast cancer
  • Diagnosis
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Internal Medicine
  • Oncology
  • Surgery

Cite this

In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women : The Mayo Clinic in Florida experience. / Bernard, Johnny Ray; Vallow, Laura A.; DePeri, Elizabeth R.; McNeil, Rebecca B.; Feigel, Deborah G.; Amar, Surabhi; Buskirk, Steven J.; Perez, Edith A.

In: Breast Journal, Vol. 16, No. 2, 03.2010, p. 118-126.

Research output: Contribution to journalArticle

Bernard, Johnny Ray ; Vallow, Laura A. ; DePeri, Elizabeth R. ; McNeil, Rebecca B. ; Feigel, Deborah G. ; Amar, Surabhi ; Buskirk, Steven J. ; Perez, Edith A. / In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women : The Mayo Clinic in Florida experience. In: Breast Journal. 2010 ; Vol. 16, No. 2. pp. 118-126.
@article{ae5c1f84c88a4a1d8a2bb7d42ed3219d,
title = "In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: The Mayo Clinic in Florida experience",
abstract = "The role of magnetic resonance imaging (MRI) in patients with newly diagnosed breast cancer is somewhat controversial. The purpose of this study was to evaluate the prevalence of synchronous, occult contralateral breast cancer detected by MRI but not by mammography or clinical breast examination in women with newly diagnosed breast cancer, including those aged 70 years or older at our institution. MRI results for women with newly diagnosed breast cancer who underwent bilateral breast MRI after negative mammography and clinical examination between February 2003 and ovember 2007 at Mayo Clinic in Florida were reviewed. The prevalence of pathologically confirmed contralateral carcinoma diagnosed solely by MRI was determined and analyzed in the context of age, family history, menopausal status, breast density, and primary-tumor characteristics. Logistic regression was used to explore the association between contralateral carcinoma and potential patient risk factors. A total of 425 women were evaluated, of whom 129 (30{\%}) were aged 70 years or older. A contralateral biopsy was recommended and performed solely on the basis of MRI in 72 of the 425 women (17{\%}). Sixteen of these 72 women (22{\%}) had pathologically confirmed carcinoma, including seven in the older subgroup. The prevalence of clinically and mammographically occult contralateral carcinoma detected by MRI was 3.8{\%} (16/425) overall and 5.4{\%} (7/129) in the group of older women. When potential risk factors for contralateral breast cancer were evaluated, postmenopausal status was the only significant predictor of contralateral cancer detected by MRI (p = 0.016). We concluded that contralateral breast screening with MRI should be considered in postmenopausal women with newly diagnosed breast cancer, even those aged 70 years or older at diagnosis",
keywords = "Breast cancer, Diagnosis, Magnetic resonance imaging",
author = "Bernard, {Johnny Ray} and Vallow, {Laura A.} and DePeri, {Elizabeth R.} and McNeil, {Rebecca B.} and Feigel, {Deborah G.} and Surabhi Amar and Buskirk, {Steven J.} and Perez, {Edith A.}",
year = "2010",
month = "3",
doi = "10.1111/j.1524-4741.2009.00890.x",
language = "English (US)",
volume = "16",
pages = "118--126",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women

T2 - The Mayo Clinic in Florida experience

AU - Bernard, Johnny Ray

AU - Vallow, Laura A.

AU - DePeri, Elizabeth R.

AU - McNeil, Rebecca B.

AU - Feigel, Deborah G.

AU - Amar, Surabhi

AU - Buskirk, Steven J.

AU - Perez, Edith A.

PY - 2010/3

Y1 - 2010/3

N2 - The role of magnetic resonance imaging (MRI) in patients with newly diagnosed breast cancer is somewhat controversial. The purpose of this study was to evaluate the prevalence of synchronous, occult contralateral breast cancer detected by MRI but not by mammography or clinical breast examination in women with newly diagnosed breast cancer, including those aged 70 years or older at our institution. MRI results for women with newly diagnosed breast cancer who underwent bilateral breast MRI after negative mammography and clinical examination between February 2003 and ovember 2007 at Mayo Clinic in Florida were reviewed. The prevalence of pathologically confirmed contralateral carcinoma diagnosed solely by MRI was determined and analyzed in the context of age, family history, menopausal status, breast density, and primary-tumor characteristics. Logistic regression was used to explore the association between contralateral carcinoma and potential patient risk factors. A total of 425 women were evaluated, of whom 129 (30%) were aged 70 years or older. A contralateral biopsy was recommended and performed solely on the basis of MRI in 72 of the 425 women (17%). Sixteen of these 72 women (22%) had pathologically confirmed carcinoma, including seven in the older subgroup. The prevalence of clinically and mammographically occult contralateral carcinoma detected by MRI was 3.8% (16/425) overall and 5.4% (7/129) in the group of older women. When potential risk factors for contralateral breast cancer were evaluated, postmenopausal status was the only significant predictor of contralateral cancer detected by MRI (p = 0.016). We concluded that contralateral breast screening with MRI should be considered in postmenopausal women with newly diagnosed breast cancer, even those aged 70 years or older at diagnosis

AB - The role of magnetic resonance imaging (MRI) in patients with newly diagnosed breast cancer is somewhat controversial. The purpose of this study was to evaluate the prevalence of synchronous, occult contralateral breast cancer detected by MRI but not by mammography or clinical breast examination in women with newly diagnosed breast cancer, including those aged 70 years or older at our institution. MRI results for women with newly diagnosed breast cancer who underwent bilateral breast MRI after negative mammography and clinical examination between February 2003 and ovember 2007 at Mayo Clinic in Florida were reviewed. The prevalence of pathologically confirmed contralateral carcinoma diagnosed solely by MRI was determined and analyzed in the context of age, family history, menopausal status, breast density, and primary-tumor characteristics. Logistic regression was used to explore the association between contralateral carcinoma and potential patient risk factors. A total of 425 women were evaluated, of whom 129 (30%) were aged 70 years or older. A contralateral biopsy was recommended and performed solely on the basis of MRI in 72 of the 425 women (17%). Sixteen of these 72 women (22%) had pathologically confirmed carcinoma, including seven in the older subgroup. The prevalence of clinically and mammographically occult contralateral carcinoma detected by MRI was 3.8% (16/425) overall and 5.4% (7/129) in the group of older women. When potential risk factors for contralateral breast cancer were evaluated, postmenopausal status was the only significant predictor of contralateral cancer detected by MRI (p = 0.016). We concluded that contralateral breast screening with MRI should be considered in postmenopausal women with newly diagnosed breast cancer, even those aged 70 years or older at diagnosis

KW - Breast cancer

KW - Diagnosis

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=77951012671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951012671&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4741.2009.00890.x

DO - 10.1111/j.1524-4741.2009.00890.x

M3 - Article

C2 - 20136645

AN - SCOPUS:77951012671

VL - 16

SP - 118

EP - 126

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 2

ER -